Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Clin Neurol Neurosurg. 2022 Jan;212:107068. doi: 10.1016/j.clineuro.2021.107068. Epub 2021 Nov 25.
The treatment of choice for chronic subdural hematoma (CSDH) has been established as burr-hole trephination with drain insertion; however, controversy remains over the best place for the drainage catheter. In this study, we compare the safety and efficacy of a subperiosteal drain (SPD) with that of a subdural drain (SDD) after one burr-hole trephination for CSDH.
This retrospective and comparative study includes all CSDH patients treated with burr-hole trephination at our institution between January 2015 and December 2019. 59 patients were treated with SPD insertion (SPD group), and 203 patients were treated with SDD insertion (SDD group).
The median hematoma thickness of the SPD group within 24 h after surgery was significantly thicker than that of the SDD group (9.5 mm vs. 7.5 mm, p = 0.003), but the midline shifting of the SPD group did not differ from that of the SDD group (3.8 mm vs. 3.5 mm, p = 0.280). The recurrence rate in the SPD group did not differ significantly from that in the SDD group (13.2% vs. 8.5%, p = 0.351). The frequency of bleeding events after surgery also did not differ significantly (5.1% vs. 3.5% p-value = 0.636). In contrast to surgery-related morbidities, medical morbidities such as pneumonia were significantly higher in the SDD group (4.4% vs. 0.0%, p = 0.044). The all-cause mortality rates during the perioperative period did not differ between the two groups (5.1% vs. 3.4%, p = 0.848).
Our findings may suggest that burr-hole trephination with SPD insertion had better surgical feasibility and fewer perioperative complications than SDD insertion. The type of anesthesia seems to be related with fewer medical complications at perioperative period. Larger, randomized clinical trials focusing not only the drain type but anesthesia type, are needed to validate our findings.
慢性硬脑膜下血肿(CSDH)的治疗选择已确立为颅骨钻孔引流术;然而,对于引流管的最佳位置仍存在争议。在这项研究中,我们比较了颅骨钻孔一次后,骨膜下引流(SPD)与硬脑膜下引流(SDD)治疗 CSDH 的安全性和疗效。
本回顾性对照研究纳入了 2015 年 1 月至 2019 年 12 月在我院接受颅骨钻孔术治疗的所有 CSDH 患者。59 例患者接受 SPD 置入(SPD 组),203 例患者接受 SDD 置入(SDD 组)。
术后 24 小时内,SPD 组血肿厚度中位数明显厚于 SDD 组(9.5mm vs. 7.5mm,p=0.003),但 SPD 组中线移位与 SDD 组无差异(3.8mm vs. 3.5mm,p=0.280)。SPD 组的复发率与 SDD 组无显著差异(13.2%vs. 8.5%,p=0.351)。术后出血事件的频率也没有显著差异(5.1%vs. 3.5%,p 值=0.636)。与手术相关的并发症相比,SDD 组的医疗并发症(如肺炎)明显更高(4.4%vs. 0.0%,p=0.044)。围手术期两组的总死亡率无差异(5.1%vs. 3.4%,p=0.848)。
我们的研究结果可能表明,颅骨钻孔引流术加 SPD 置入术比 SDD 置入术具有更好的手术可行性和更少的围手术期并发症。麻醉类型似乎与围手术期的医疗并发症较少有关。需要更大规模、随机临床试验,不仅关注引流管类型,还关注麻醉类型,以验证我们的研究结果。